MICHAEL FRUMOVITZ to Radiopharmaceuticals
This is a "connection" page, showing publications MICHAEL FRUMOVITZ has written about Radiopharmaceuticals.
Connection Strength
0.360
-
PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study. Int J Gynecol Cancer. 2023 11 06; 33(11):1690-1694.
Score: 0.150
-
Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol. 2017 04; 145(1):96-101.
Score: 0.094
-
Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging. Int J Gynecol Cancer. 2012 Sep; 22(7):1203-7.
Score: 0.069
-
Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study. Cancer. 2019 10 01; 125(19):3347-3353.
Score: 0.028
-
Aggressive angiomyxomas: a comprehensive imaging review with clinical and histopathologic correlation. AJR Am J Roentgenol. 2014 Jun; 202(6):1171-8.
Score: 0.019